Latest Key Developments (Source: Significant Developments)
Skystar Bio Pharmaceutical Co Reaffirms FY 2013 Revenue Guidance
Skystar Bio-Pharmaceutical Company reiterated fiscal 2013 revenue guidance to be in the range of $40 million to $45 million. Full Article
Skystar Bio Pharmaceutical Co Reiterates FY 2012 Revenue Guidance
Skystar Bio-Pharmaceutical Company reiterated fiscal 2012 revenue guidance to be in the range of $53 million to $57 million. Full Article
Skystar Bio-Pharmaceutical Company Reiterates FY 2012 Revenue Guidance
Skystar Bio-Pharmaceutical Company reiterated fiscal 2012 revenue guidance range of $53 million to $57 million. Full Article
Skystar Bio-Pharmaceutical Company Issues FY 2012 Revenue Guidance
Skystar Bio-Pharmaceutical Company announced that for fiscal 2012, it expects top line revenue in the range of $53 million to $57 million. Full Article
Skystar Bio-Pharmaceutical Company Reaffirms FY 2011 Revenue Guidance
Skystar Bio-Pharmaceutical Company announced that it expects in meeting revised top line revenue guidance of $52 million to $55 million for fiscal 2011. Full Article
Skystar Bio-Pharmaceutical Company Lowers FY 2011 Revenue Guidance
Skystar Bio-Pharmaceutical Company announced that for fiscal 2011, it expects revenue guidance to be in the range of $52 million to $55 million. Full Article
Skystar Bio-Pharmaceutical Company Appoints New Chief Financial Officer
Skystar Bio-Pharmaceutical Company announced the appointment of Mr. Bing Mei to become the Company's permanent Chief Financial Officer (CFO), effective as of July 29, 2011. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
